Skip to content

ABIOMED INC

Delisted

CIK 815094fmd_0W5W6NE2VDT1Y3VQZ41TB6ZG1NManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Apr 01, 2009 to Sep 30, 2022, 51 periods

Latest annual · FY2022

Millions
Total revenues
1,032
Gross profit
844
Operating income
141
Net income
137
Free cash flow
250

Latest quarter · Q2 FY2023

Millions
Total revenues
266
Gross profit
217
Operating income
58
Net income
106
Free cash flow
8
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
+10.3%
Revenue, 5 yearsFY2017 to FY2022
+18.3%
Net income, 5 yearsFY2017 to FY2022
+21.2%

ABIOMED INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$1 billion$847.5 million+21.7%10-K 2022-05-20 · proof
Gross profit$843.6 million$685.6 million+23%10-K 2022-05-20 · proof
Operating income$140.7 million$229.6 million-38.7%10-K 2022-05-20 · proof
Net income$136.5 million$225.5 million-39.5%10-K 2022-05-20 · proof
Cash from operating activities$285.4 million$274.6 million+3.9%10-K 2022-05-20 · proof
Free cash flow$249.6 million$221.2 million+12.9%10-K 2022-05-20 · proof
Total assets$1.7 billion$1.5 billion+12%10-K 2022-05-20 · proof
Total liabilities$170.1 million$164.7 million+3.3%10-K 2022-05-20 · proof
Cash and cash equivalents$132.8 million$232.7 million-42.9%10-K 2022-05-20 · proof
What was ABIOMED INC's revenue in fiscal 2022?
ABIOMED INC reported revenue of $1 billion for fiscal 2022 (the year ended Mar 31, 2022), against $847.5 million the year before (+21.7%). Source: the 10-K filed with the SEC on May 20, 2022. SEC
What was ABIOMED INC's gross profit in fiscal 2022?
ABIOMED INC reported gross profit of $843.6 million for fiscal 2022 (the year ended Mar 31, 2022), against $685.6 million the year before (+23%). Source: the 10-K filed with the SEC on May 20, 2022. SEC
What was ABIOMED INC's operating income in fiscal 2022?
ABIOMED INC reported operating income of $140.7 million for fiscal 2022 (the year ended Mar 31, 2022), against $229.6 million the year before (-38.7%). Source: the 10-K filed with the SEC on May 20, 2022. SEC
What was ABIOMED INC's net income in fiscal 2022?
ABIOMED INC reported net income of $136.5 million for fiscal 2022 (the year ended Mar 31, 2022), against $225.5 million the year before (-39.5%). Source: the 10-K filed with the SEC on May 20, 2022. SEC
What was ABIOMED INC's cash from operating activities in fiscal 2022?
ABIOMED INC reported cash from operating activities of $285.4 million for fiscal 2022 (the year ended Mar 31, 2022), against $274.6 million the year before (+3.9%). Source: the 10-K filed with the SEC on May 20, 2022. SEC
What was ABIOMED INC's free cash flow in fiscal 2022?
ABIOMED INC reported free cash flow of $249.6 million for fiscal 2022 (the year ended Mar 31, 2022), against $221.2 million the year before (+12.9%). Source: the 10-K filed with the SEC on May 20, 2022. SEC
What are ABIOMED INC's total assets?
As of Mar 31, 2022, ABIOMED INC reported total assets of $1.7 billion, against $1.5 billion a year earlier (+12%). Source: the 10-K filed with the SEC on May 20, 2022. SEC
What are ABIOMED INC's total liabilities?
As of Mar 31, 2022, ABIOMED INC reported total liabilities of $170.1 million, against $164.7 million a year earlier (+3.3%). Source: the 10-K filed with the SEC on May 20, 2022. SEC
What are ABIOMED INC's cash and cash equivalents?
As of Mar 31, 2022, ABIOMED INC reported cash and cash equivalents of $132.8 million, against $232.7 million a year earlier (-42.9%). Source: the 10-K filed with the SEC on May 20, 2022. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:815094&period_type=annual&limit=5"

Information only, not investment advice.